Vnitr Lek 2005, 51(12):1412

Dopis redakci. Přínos pioglitazonu u pacientů s diabetes mellitus 2. typu a kardiovaskulárními komplikacemi

J. Olšovský
Diabetologické centrum II. interní kliniky Lékařské fakulty MU a FN u sv. Anny, Brno, přednosta doc. MUDr. Miroslav Souček, CSc.

Received: October 31, 2005; Published: December 1, 2005  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Olšovský J. Dopis redakci. Přínos pioglitazonu u pacientů s diabetes mellitus 2. typu a kardiovaskulárními komplikacemi. Vnitr Lek. 2005;51(12):1412.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Domandy JA et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspektive pioglitAzone Clinical Trial in macroVascular Events): a randomised controlled trial.
    2. Kvapil M. Doba post-statinová. Současné trendy ve snižování rizika kardiovaskulárních komplikací cestou farmakologické intervence sérových lipidů u pacientů s diabetes mellitus 2. typu. In: Perušičová J (ed). Diabetologie 2005. Praha: Triton 2005: 59-79.
    3. Proactive - výsledky studie, prezentace na EASD, www.proactive-reults.com

    Return to the content


    Vnitřní lékařství

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.